SCHEMBL8934550

SCHEMBL8934550

CCOC(=O)COc1ccc(O)c2c(=O)cc(-c3ccccc3)oc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.66
POLB P06746 2/20 0.66
CYP2C9 P11712 2/20 0.66
HPGD P15428 2/20 0.66
CYP2C19 P33261 2/20 0.66
CYP1A2 P05177 2/20 0.66
ALDH1A1 P00352 1/20 0.66
CYP3A4 P08684 1/20 0.66
KDM5A P29375 1/20 0.53
EGFR P00533 11/20 0.52
ACHE P22303 1/20 0.51
PLK1 P53350 1/20 0.51
BACE1 P56817 1/20 0.51
RET P07949 1/20 0.51
KDR P35968 1/20 0.51
CREB1 P16220 1/20 0.50
GABRP O00591 1/20 0.50
GABRD O14764 1/20 0.50
KDM1A O60341 1/20 0.50
CCNT1 O60563 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8934583 0.87 ACHE (0.54) KDM4EPOLBCYP2C9HPGDCYP2C19
SCHEMBL9139841 0.81 HPGD (0.80) KDM4EPOLBCYP2C9HPGDCYP2C19
SCHEMBL4053857 0.80 KDM4E (0.80) KDM4EPOLBCYP2C9HPGDCYP2C19
SCHEMBL30738943 0.79 ACHE (0.73) KDM4ECYP2C9HPGDCYP2C19CYP1A2
SCHEMBL8934497 0.79 CYP2D6 (0.52) CYP1A2ALDH1A1CYP3A4EGFRACHE
SCHEMBL28848654 0.76 KDM5A (0.52) KDM4EPOLBCYP2C9HPGDCYP2C19
SCHEMBL4783697 0.75 ALDH1A1 (0.67) KDM4ECYP2C9HPGDCYP2C19CYP1A2
SCHEMBL8429610 0.74 DYRK1A (0.48) KDM4EPOLBCYP2C9HPGDCYP2C19
Efloxate SCHEMBL309159 0.73 KDM4E (1.00) KDM4EPOLBCYP2C9HPGDCYP2C19
SCHEMBL8427304 0.72 DYRK1A (0.52) KDM4EPOLBCYP2C9HPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO claimed
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO disclosed